You are here

Article Text

Article menu
Download PDFPDF
Letter
Use of intravenous cyclizine in cardiac chest pain
  1. R A Cooke1,
  2. M W Cooke2
  1. 1Worcestershire, UK
  2. 2Emergency Medicine Department, University of Warwick, UK
  1. Correspondence to:
 R A Cooke
 Worcestershire, UK; roger{at}vwfmed.fsnet.co.uk

https://doi.org/10.1136/emj.2006.034751

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    May and Kumar1 conclude that “cyclizine should be avoided in patients with acute coronary events”, although we note that the BETs online version states “there appears to be no firm evidence that cyclizine increases morbidity and mortality in patients with myocardial ischaemia”. They reviewed a single 16–year–old study, which looked at a small number of patients suffering from heart …

    View Full Text

    Footnotes

    • Competing interests: None declared.